|
" Neuromethods. 26 : "
program eds.: Alan A. Boulton and Glen B. Baker ; ed. by Alan A. Boulton, Glen B. Baker and Wolfgang Walz
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
740020
|
| Doc. No
|
:
|
b559953
|
| Main Entry
|
:
|
program eds.: Alan A. Boulton and Glen B. Baker ; ed. by Alan A. Boulton, Glen B. Baker and Wolfgang Walz
|
| Title & Author
|
:
|
Neuromethods. 26 : : Patch-clamp applications and protocols\ program eds.: Alan A. Boulton and Glen B. Baker ; ed. by Alan A. Boulton, Glen B. Baker and Wolfgang Walz
|
| Publication Statement
|
:
|
1995
|
| Page. NO
|
:
|
bd. : illustrations
|
| ISBN
|
:
|
0896033112
|
|
|
:
|
: 9780896033115
|
| Notes
|
:
|
Eks. 1=Bortkommet 2002. Eks. 2=Erstatningseks.;Bd. 1-3, 4?, 5, 7? og 8 med undertitlen: series 1: Neurochemistry
|
| Contents
|
:
|
26. Patch-clamp applications and protocols / ed. by Alan A. Boulton, Glen B. Baker and Wolfgang Walz 1995 Eks. 1=Bortkommet 2002. Eks. 2=Erstatningseks.
|
| LC Classification
|
:
|
QH585.P764 1995
|
| Added Entry
|
:
|
Ralph N Adams
|
| Parallel Title
|
:
|
Apoptosis techniques and protocols;Regulatory protein modification;G protein methods and protocols;General neurochemical techniques;Amines and their metabolites;Amino acids;Receptor binding;Neurotransmitter enzymes;Neuropeptide techniques;Peptides;Lipids and related compounds;Imaging and correlative physicochemical techniques;Neuronal microenvironment;Analysis of psychiatric drugs;Carbohydrates and energy metabolism;Drugs as tools in neurotransmitter research;Psychopharmacology;Molecular neurobiological techniques;Neurophysiological techniques;Neuropsychology;Animal models in psychiatry;Intracellular messengers;Animal models of neurological disease;Practical cell culture techniques;Animal models of drug addiction;Neurotrophic factors;In vitro neurochemical techniques;Cell neurobiology techniques;In vivo neuromethods;Neural transplantation methods;Patch-clamp analysis;Mood and anxiety related phenotypes in mice;Calcium measurement methods;Transgenic and mutant tools to model brain disorders;Drug delivery to the central nervous system;Animal models for retinal diseases
|
| |